METiS Joins the Roche Accelerator
METiS today announced officially joining the Roche Accelerator with the goal to tap into Roches global scientific expertise, laboratory facilities and foster collaboration discussions on formulation development and optimization with Roche Innovation Center Shanghai.
- METiS today announced officially joining the Roche Accelerator with the goal to tap into Roches global scientific expertise, laboratory facilities and foster collaboration discussions on formulation development and optimization with Roche Innovation Center Shanghai.
- "We are excited to become a member of the Roche Accelerator and to establish a closer connection with a global leader in healthcare like Roche," said Chris Lai, co-founder and CEO of METiS.
- We look forward to testing METiS proprietary AiTEM platform together and exploring deeper collaboration opportunities to bring optimized therapeutics to patients around the world.
- Dr. Qiusong Tang, Head of Roche Accelerator, said: We have been witnessing digitalization and AI along the entire pharma R&D value chain, and Im very glad to welcome METiS as the first Roche Accelerator portfolio start-up focusing on AI.